High throughput CRISPR Cas cell line generation using the CellRaft Array platform
Award amount
$250,780Program and phase
STTR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CELL MICROSYSTEMS INC
- Proposal award date
- 2017-05-01
- Contract end date
- 2019-04-30
- UEI
- G51EN7YDH7F3
- Solicitation number
- PA16-303
- Topic code
- NHGRI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem
- Rapid identification and selection of functional antigen-specific monoclonal antibodies by FcGR-enabled screening on CytoSort Arrays in the CellRaft AIR System
- Improving iPSC reprogramming and CRISPR gene editing workflows and efficacy using CellRaft technology
- Three-dimensional organoid culture using the CellRaft microwell technology
- THE THE PURPOSE OF THE PHASE II PROGRAM IS TO FOCUS ON DEVELOPING A T-CELL ACTIVATION PROTOCOL CONSISTENT WITH REPORTERCELL VIABILITY, DEVELOPING A PR
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform to support clinical variant interpretation through probabilistic assessment of functional evidence
- Innovations to expand and accelerate the commercial impact of DNA modifications
- High-throughput Direct Sequencing and Quantitative Mapping of RNA Modifications using Mass Spectrometry.
- Super-resolution single-molecule sequencing by observing the dynamic hybridization of a repertoire of oligonucleotides to DNA targets
- Exhaustive de novo sequencing of every RNA in a sample by a layer-by-layer mass spectrometry ladder intensity approach.
Research funding history
19 SBIR/STTR records share this UEI (2013–2023). Reported award amounts total $15,051,342. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services